PREDICTIVE SIGNIFICANCE OF IDH1/2 MUTATION AND 1P/19Q CO-DELETION STATUS IN A POST-HOC ANALYSIS OF NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT plus PCV IN HIGH RISK LOW-GRADE GLIOMAS Conference

cited authors

  • Bell, Erica H; Zhang, Peixin; Shaw, Edward G; Buckner, Jan C; Barger, Geoffrey R; Coons, Stephen W; Bullard, Dennis E; Mehta, Minesh P; Gilbert, Mark R; Brown, Paul D; Stelzer, Keith J; Fleming, Jessica; McElroy, Joseph P; Timmers, Cynthia D; Becker, Aline Paixao; Salavaggione, Andrea L; Liu, Ziyan; Aldape, Ken; Brachman, David G; Gertler, Stanley Z; Murtha, Albert D; Schultz, Christopher J; Johnson, David; Shu, Hui-Kuo; Chakravarti, Arnab

fiu authors

publication date

  • November 1, 2017

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • San Francisco, CA

Conference

  • Joint Conference of 22nd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology / Conference of the Society-for-CNS-Interstitial-Delivery-of-the-Therapeutics (SCIDOT) on Therapeutic Delivery to the CNS

start page

  • 8

end page

  • 8

volume

  • 19